That's the title that Science magazine is bestowing upon the medication called lenacapavir — a twice yearly injectable that ...

The US journal "Science" has named the development of the drug Lenacapavir as this year's "Breakthrough of the Year". The ...

That's the title that Science magazine is bestowing upon the medication called lenacapavir — a twice yearly injectable that ...

The drug lenacapavir, developed by Gilead Sciences, provides protection for half a year instead of one day and has performed extremely well in clinical trials.

LOS ANGELES, Dec. 13 (Xinhua) -- An injectable HIV drug with novel mechanism was named on Thursday by the influential U.S. journal "Science" as Breakthrough of the Year. The drug, named lenacapavir, ...

Lenacapavir, a treatment administered subcutaneously every six months, is capable of preventing infection with very high ...

But doing so still requires “substantial breakthroughs in synthetic cell research”, the scientists said. HIV gamechanger: Lenacapavir study participant explains Although the capability to engineer ...

Science, a global scientific journal, has selected lenacapavir (lenacapavir), a groundbreaking HIV infection treatment, and related studies for the '2024 Innovation of the Year'. Renacapavir, an ...

Passive consumption of social media seems to reinforce feelings of disconnection, according to a JRC policy brief which examines the relationship between social media use and loneliness ...

Dec. 9, 2024 — Researchers found that adolescents with more symptoms of gaming addiction showed lower brain activity in the region involved in decision-making and reward processing; this blunted ...

Stay informed on Saudi Arabia’s rapid changes, developments, and ongoing efforts to reshape the Middle East and beyond.